다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
유럽
EU
Innate Pharma (IPH)
Innate Pharma (IPH) 뉴스

IPH

Innate Pharma (IPH)

Innate Pharma

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:EU:IPH

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/12/19	21:38	MF Dow Jones (Italiano)	Le azioni di Innate Pharma salgono dopo l'esercizio dell'opzione dilicenza da parte di Sanofi	EU:IPH	Innate Pharma
2023/12/19	21:28	Dow Jones News	Innate Pharma Shares Rise after Sanofi Exercises Licensing Option	EU:IPH	Innate Pharma
2023/12/19	16:39	Dow Jones News	Sanofi exerce une option de licence en oncologie auprès d'Innate Pharma	EU:IPH	Innate Pharma
2023/12/19	16:34	Dow Jones News	Sanofi exerce une option de licence en oncologie auprès d'Innate Pharma	EU:IPH	Innate Pharma
2023/10/05	21:14	Dow Jones News	Innate Pharma Shares Fall Premarket on FDA Partial Study Hold	EU:IPH	Innate Pharma
2023/06/08	23:53	Dow Jones News	Innate Pharma Shares Rise 8% After Cancer Treatment Gets Fast Track Designation	EU:IPH	Innate Pharma
2022/12/19	16:25	Dow Jones News	Sanofi et Innate Pharma étendent leur collaboration en oncologie avec les cellules NK	EU:IPH	Innate Pharma
2022/08/01	19:30	Dow Jones News	Innate Pharma Shares Slide After Failure of Monalizumab in Head, Neck Cancer	EU:IPH	Innate Pharma
2021/09/23	14:00	GlobeNewswire Inc.	Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er septembre 2021	EU:IPH	Innate Pharma
2021/09/23	14:00	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021	EU:IPH	Innate Pharma
2021/09/23	14:00	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021	EU:IPH	Innate Pharma
2021/09/17	20:45	GlobeNewswire Inc.	Monalizumab Data From COAST Trial Presented at ESMO Congress 2021	EU:IPH	Innate Pharma
2021/09/17	20:45	GlobeNewswire Inc.	Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021	EU:IPH	Innate Pharma
2021/09/17	20:45	GlobeNewswire Inc.	Monalizumab Data from COAST Trial Presented at ESMO Congress 2021	EU:IPH	Innate Pharma
2021/09/15	14:00	GlobeNewswire Inc.	Innate Pharma reports first half 2021 financial results and business update	EU:IPH	Innate Pharma
2021/09/15	14:00	GlobeNewswire Inc.	Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2021	EU:IPH	Innate Pharma
2021/09/15	14:00	GlobeNewswire Inc.	Rapport Financier Semestriel 30 juin 2021	EU:IPH	Innate Pharma
2021/09/15	14:00	GlobeNewswire Inc.	Innate Pharma Reports First Half 2021 Financial Results and Business Update	EU:IPH	Innate Pharma
2021/09/07	14:00	GlobeNewswire Inc.	Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021	EU:IPH	Innate Pharma
2021/09/07	14:00	GlobeNewswire Inc.	Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update	EU:IPH	Innate Pharma
2021/09/07	14:00	GlobeNewswire Inc.	Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update	EU:IPH	Innate Pharma
2021/09/02	15:00	GlobeNewswire Inc.	Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress	EU:IPH	Innate Pharma
2021/09/02	15:00	GlobeNewswire Inc.	Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021	EU:IPH	Innate Pharma
2021/09/02	15:00	GlobeNewswire Inc.	Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress	EU:IPH	Innate Pharma
2021/08/30	14:00	GlobeNewswire Inc.	Innate Pharma to Participate in Upcoming Investor Conferences	EU:IPH	Innate Pharma
2021/08/30	14:00	GlobeNewswire Inc.	Innate Pharma to Participate in Upcoming Investor Conferences	EU:IPH	Innate Pharma
2021/08/30	14:00	GlobeNewswire Inc.	Prochains Rendez-Vous Investisseurs d'Innate Pharma	EU:IPH	Innate Pharma
2021/08/11	14:00	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021	EU:IPH	Innate Pharma
2021/08/11	14:00	GlobeNewswire Inc.	Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Aout 2021	EU:IPH	Innate Pharma
2021/08/11	14:00	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021	EU:IPH	Innate Pharma

검색 관련기사 보기:EU:IPH

1 2 3 4 5 6 7 8 9 10 다음 >>

Vontobel Financial Produ...

BNP Paribas Issuance

BNP Paribas Issuance

Vanguard FTSE Dev All Ca...

BNP Paribas Issuance

Vontobel Financial Produ...

Denali Therapeutics

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관